Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses

Background: In animal models, variations in early maternal care are associated with differences in hypothalamic-pituitary-adrenal (HPA) stress response in the offspring, mediated via changes in the epigenetic regulation of glucocorticoid receptor (GR) gene (Nr3c1) expression. Objective: To study this in humans, relationships between prenatal exposure to maternal mood and the methylation status of a CpG-rich region in the promoter and exon 1F of the human GR gene (NR3C1) in newborns and HPA stress reactivity at age 3 months were examined. Methods: The methylation status of a CpG-rich region of the NR3C1 gene, including exon 1F, in genomic DNA from cord blood mononuclear cells was quantified by bisulfite pyrosequencing in infants of depressed mothers treated with a serotonin reuptake inhibitor antidepressant (SRI) (n=33), infants of depressed non treated mothers (n=13) and infants of non depressed/non treated mothers (n=36). To study the functional implications of the newborn methylation status of NR3C1 in newborns, HPA function was assessed at 3 months using salivary cortisol obtained before and following a non noxious stressor and at a late afternoon basal time. Results: Prenatal exposure to increased third trimester maternal depressed/anxious mood was associated with increased methylation of NR3C1 at a predicted NGFI-A binding site. Increased NR3C1 methylation at this site was also associated with increased salivary cortisol stress responses at 3 months, controlling for prenatal SRI exposure, postnatal age, and pre and postnatal maternal mood. Conclusions: Methylation status of the human NR3C1 gene in newborns is sensitive to prenatal maternal mood and may offer a potential epigenetic process that links antenatal maternal mood and altered HPA stress reactivity during infancy.

[1]  Maarten Mennes,et al.  Antenatal maternal anxiety and stress and the neurobehavioural development of the fetus and child: links and possible mechanisms. A review , 2005, Neuroscience & Biobehavioral Reviews.

[2]  M. Meaney,et al.  Maternal care as a model for experience-dependent chromatin plasticity? , 2005, Trends in Neurosciences.

[3]  J. Seckl,et al.  The effect of chronic fluoxetine treatment on brain corticosteroid receptor mRNA expression and spatial memory in young and aged rats. , 2002, Brain research. Molecular brain research.

[4]  M. Bornstein,et al.  Information processing and developmental assessments in 3-month-old infants exposed prenatally to cocaine. , 1995, Pediatrics.

[5]  P. Riederer,et al.  The glucocorticoid receptor gene exon 1-F promoter is not methylated at the NGFI-A binding site in human hippocampus , 2007, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[6]  J. Issa,et al.  A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. , 2004, Nucleic acids research.

[7]  R. Kofler,et al.  Identification, tissue expression, and glucocorticoid responsiveness of alternative first exons of the human glucocorticoid receptor. , 2007, Journal of molecular endocrinology.

[8]  R Alexandra Goldbohm,et al.  Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. , 2003, Cancer research.

[9]  J. Cox,et al.  Detection of Postnatal Depression , 1987, British Journal of Psychiatry.

[10]  P. Reebye,et al.  Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. , 2007, Archives of pediatrics & adolescent medicine.

[11]  J. Marcusson,et al.  Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of antidepressants in the rat , 2000, Psychopharmacology.

[12]  C. Nemeroff,et al.  Hypercortisolemia and depression. , 2005, Psychosomatic medicine.

[13]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[14]  C. Davis,et al.  DNA Methylation, Cancer Susceptibility, and Nutrient Interactions , 2004, Experimental biology and medicine.

[15]  M. Meaney,et al.  The role of serotonin in the development and environmental regulation of type II corticosteroid receptor binding in rat hippocampus. , 1990, Brain research. Developmental brain research.

[16]  R. Grunau,et al.  Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding. , 2006, British journal of clinical pharmacology.

[17]  T. Field,et al.  PRENATAL MATERNAL BIOCHEMISTRY PREDICTS NEONATAL BIOCHEMISTRY , 2004, The International journal of neuroscience.

[18]  C. Muller,et al.  Structure of the glucocorticoid receptor (NR3C1) gene 5' untranslated region: identification, and tissue distribution of multiple new human exon 1. , 2005, Journal of molecular endocrinology.

[19]  J. Seckl,et al.  Prenatal Stress, Glucocorticoids and the Programming of the Brain , 2001, Journal of neuroendocrinology.

[20]  T. Perneger.  What's wrong with Bonferroni adjustments , 1998, BMJ.

[21]  Michael J Meaney,et al.  Epigenetic programming by maternal behavior , 2004, Nature Neuroscience.

[22]  J. Rosenbaum,et al.  Obstetrical and Neonatal Outcome following Clonazepam Use during Pregnancy: A Case Series , 2001, Psychotherapy and Psychosomatics.

[23]  T. O'Connor,et al.  Maternal antenatal anxiety and behavioural/emotional problems in children: a test of a programming hypothesis. , 2003, Journal of child psychology and psychiatry, and allied disciplines.

[24]  Shakti Sharma,et al.  Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. , 1997, Science.

[25]  I. Weaver,et al.  The Transcription Factor Nerve Growth Factor-Inducible Protein A Mediates Epigenetic Programming: Altering Epigenetic Marks by Immediate-Early Genes , 2007, The Journal of Neuroscience.

[26]  M. Meaney,et al.  Nongenomic transmission across generations of maternal behavior and stress responses in the rat. , 1999, Science.

[27]  Thomas Werner,et al.  MatInspector and beyond: promoter analysis based on transcription factor binding sites , 2005, Bioinform..

[28]  J. Seckl,et al.  Differential regulation of variant glucocorticoid receptor mRNAs in the rat hippocampus by the antidepressant fluoxetine. , 2004, Brain research. Molecular brain research.

[29]  I. Gut,et al.  De novo quantitative bisulfite sequencing using the pyrosequencing technology. , 2004, Analytical biochemistry.

[30]  C. Hertzman,et al.  Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. , 2006, Archives of general psychiatry.

[31]  M. Weinstock.  Does Prenatal Stress Impair Coping and Regulation of Hypothalamic-Pituitary-Adrenal Axis? , 1997, Neuroscience & Biobehavioral Reviews.

[32]  M. Meaney,et al.  Serotonin regulates hippocampal glucocorticoid receptor expression via a 5-HT7 receptor. , 2002, Brain research. Developmental brain research.

[33]  M. Hamilton.  The assessment of anxiety states by rating. , 1959, The British journal of medical psychology.

[34]  A. Fleming,et al.  Neurobiology of mother–infant interactions: experience and central nervous system plasticity across development and generations , 1999, Neuroscience & Biobehavioral Reviews.

[35]  M. Meaney,et al.  Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. , 2001, Annual review of neuroscience.

[36]  E. Simpson,et al.  Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications , 2008, Molecular Psychiatry.

[37]  J. Prickaerts,et al.  Prenatal stress and neonatal rat brain development , 2006, Neuroscience.

[38]  M. Meaney,et al.  5'-heterogeneity of glucocorticoid receptor messenger RNA is tissue specific: differential regulation of variant transcripts by early-life events. , 2000, Molecular endocrinology.

[39]  R. Yando,et al.  Prenatal depression effects on the fetus and the newborn , 2004 .

[40]  P. Wadhwa,et al.  The association between prenatal stress and infant birth weight and gestational age at birth: a prospective investigation. , 1993, American journal of obstetrics and gynecology.

[41]  D. Abbott,et al.  Long-term effects of prenatal stress on HPA axis activity in juvenile rhesus monkeys. , 1994, Developmental psychobiology.

[42]  D. Bogen,et al.  Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. , 2005, JAMA.

[43]  T. Oberlander,et al.  Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. , 2004, The Journal of clinical psychiatry.

[44]  Laetitia P. L. Pelascini,et al.  Tissue specific glucocorticoid receptor expression, a role for alternative first exon usage? , 2006, Biochemical pharmacology.

[45]  A. Parent,et al.  Early environmental regulation of hippocampal glucocorticoid receptor gene expression: characterization of intracellular mediators and potential genomic target sites , 2001, Molecular and Cellular Endocrinology.

[46]  M. Breslin,et al.  Multiple promoters exist in the human GR gene, one of which is activated by glucocorticoids. , 2001, Molecular endocrinology.